Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality rehab aims to bring stroke therapy home

NCT ID NCT04620707

Disease control Sponsor: Institute for Bioengineering of Catalonia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial tests a virtual reality system called RGS that guides stroke survivors through reaching, grasping, and placing virtual objects to aid motor and cognitive recovery. The study enrolls adults who have had a first stroke with mild to moderate arm weakness. Participants use the system in the clinic and then at home for three months, with monitoring via a wearable device. Researchers measure changes in daily functioning and arm movement over a year to see if this approach can extend rehabilitation beyond the clinic.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Rehabilitation Gaming System (RGS), a virtual reality-based training and monitoring device for motor and cognitive rehabilitation
What this could lead to
If it works, this could make intensive, personalized rehabilitation available at home for stroke survivors, potentially speeding recovery and improving quality of life.
What could go wrong
This is a small early-stage study, and the technology may not prove more effective than standard rehab or may be difficult for some patients to use at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

Nov 2020

Finished

Aug 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Patients presenting a first-ever ischemic or intracerebral hemorrhagic stroke. * A CT SCAN and/or MRI had exclude other pathologies. * Lesion localization by clinical symptoms/signs. * Moderate to mild proximal upper limb motor impairment (MRC≥2). * Age 20-85 years old. * Able to sit on a chair or a wheelchair interacting with the RGS during a full session, and be capable and willing to participate in RGS therapy. Exclusion criteria: * Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient or the quality of the data. * Severe cognitive capabilities that prevent the execution of the experiment (MoCA \< 19). This cut-off score is based on pilot study (Maier, M. et al, 2019). * Arteriovenous malformation or lesions not related with a stroke. * Severe associated impairment such as spasticity, communication disabilities (sensorial, Wernicke aphasia or apraxia), major pain or other neuromuscular impairments or orthopedic devices that would interfere with the correct execution of the experiment (Modified Ashworth Scale \< 3). * Unable to use the RGS independently according to the therapist's observations and lacking support from a caregiver to use the RGS. * Refusal to sign the consent form. * Pre-stroke history of upper limb motor disability.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fatigue hemiplegia intracerebral hemorrhage ischemic stroke Paresis stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic stroke Hemiparesis Stroke Subacute stroke

Contacts and locations

Locations

  • University Miguel Hernandez - Specs Lab

    Elche, Alicante, 03202, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.